LOCALLY ADVANCED PROSTATE CANCER
Clinical trials for LOCALLY ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to cut hormone therapy in prostate cancer
Disease control Recruiting nowThis trial is testing whether combining the drug Pluvicto with precise radiation (SBRT) can lower the chance of cancer returning in men with locally advanced prostate cancer, while also reducing the need for long-term hormone therapy. About 45 participants will receive one to thr…
Matched conditions: LOCALLY ADVANCED PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Angela Y. Jia, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New pill combo aims to boost prostate cancer cure rates
Disease control Recruiting nowThis early-phase trial is testing whether taking two hormone-blocking pills—relugolix and enzalutamide—before and after standard radiation or surgery can help cure high-risk locally advanced prostate cancer. About 46 men will participate to first find a safe dose, then see if the…
Matched conditions: LOCALLY ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can a precise radiation boost beat prostate cancer relapse?
Disease control Recruiting nowThis trial is testing two improvements to standard radiation therapy for men with high-risk prostate cancer. First, it adds a higher radiation dose (a boost) directly to the visible tumor inside the prostate, aiming to reduce the chance of cancer spreading. Second, it compares gi…
Matched conditions: LOCALLY ADVANCED PROSTATE CANCER
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Triple-Drug attack before prostate surgery shows promise in early trial
Disease control Recruiting nowThis study tests whether adding two drugs—fasudil hydrochloride and a PD-1 inhibitor—to standard hormone therapy before prostate cancer surgery can better shrink or eliminate tumors. About 83 men with locally advanced or limited metastatic prostate cancer will receive either the …
Matched conditions: LOCALLY ADVANCED PROSTATE CANCER
Phase: PHASE2, PHASE3 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo therapy aims to wipe out prostate tumors before surgery
Disease control Recruiting nowThis Phase 2 trial tests whether adding homoharringtonine, a drug from a plant, to standard hormone therapy can better shrink or eliminate prostate cancer before surgery. About 96 men with locally advanced or limited spread prostate cancer will receive either the drug combo or a …
Matched conditions: LOCALLY ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 26, 2026 14:51 UTC